Effects of high dietary fat and cholesterol on expression of PPARα, LXRα, and their responsive genes in the liver of apoE and LDLR double deficient mice

Molecular and Cellular Biochemistry

Volumn 323, Issue 1-2, 2009, Pages 195-205

  Zou, Yanyan ^a   Du, Hui ^a   Yin, Miao ^a   Zhang, Liang ^a   Mao, Liufeng ^a   Xiao, Ning ^a   Ren, Guocheng ^a   Zhang, Cong ^a   Pan, Jie ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

ApoE LDLR DKO; Atherosclerosis; Lipid metabolism; Liver; LXR ; PPAR

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; ANGIOPOIETIN; ANGIOPOIETIN 3; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; APOLIPOPROTEIN F; CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; FATTY ACID SYNTHASE; LIPID; LIPOPROTEIN LIPASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; C57BL 6 MOUSE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DOWN REGULATION; FAT INTAKE; GENE EXPRESSION REGULATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIET; DIETARY FATS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; ORPHAN NUCLEAR RECEPTORS; PPAR ALPHA; RECEPTORS, LDL;

MUS;

EID: 59949098866     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9982-3     Document Type: Article

References (43)

1. Steinberg D (2005) Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin. Mol Nutr Food Res 49:995-998. doi: 10.1002/mnfr.200500081
2. Reddick RL, Zhang SH, Maeda N et al (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14:141-147
3. Krauss RM (2004) Insulin resistance syndrome and dyslipidemia. Endocr Pract 9(Suppl 2):67-72
4. Recinos A, Carr BK, Bartos DB et al (2004) Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: Induction of components of alternative complement pathway. Physiol Genomics 19:131-142. doi: 10.1152/physiolgenomics.00146.2003
5. De Souza AT, Dai X, Spencer AG et al (2006) Transcriptional and phenotypic comparisons of PPARα knockout and siRNA knockdown mice. Nucleic Acids Res 34:4486-4494. doi: 10.1093/nar/gkl609
6. Ricote M, Valledor AF, Glass CK (2004) Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: Effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24:230-239. doi: 10.1161/01.ATV.0000103951.67680.B1
7. Li AC, Glass CK (2004) PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 45:2161-2173. doi: 10.1194/jlr.R400010-JLR200
8. Barbier O, Torra IP, Duguay Y et al (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22:717-726. doi: 10.1161/ 01.ATV.0000015598.86369.04
9. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925
10. De Craemer D, Vamecq J, Roels F et al (1994) Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high fat diets. J Lipid Res 35:1241-1250
11. Orellana M, Fuentes O, Rosenbluth H et al (1992) Modulation of rat liver peroxisomal and microsomal fatty acid oxidation by starvation. FEBS Lett 310:193-196. doi: 10.1016/0014-5793(92)81327-I
12. Schultz JR, Tu H, Luk A et al (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838. doi: 10.1101/gad.850400
13. Joseph SB, Laffitte BA, Patel PH et al (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277:11019-11025. doi: 10.1074/ jbc.M111041200
14. Patsch W, Gotto AM Jr (1995) High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: Pathophysiology and management. Adv Pharmacol 32:375-426. doi: 10.1016/S1054-3589(08)61018-2
15. Gordon DJ, Rifkind BM (1989) High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 321:1311-1316
16. Foger B, Chase M, Amar MJ et al (1999) Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem 274:36912-36920. doi: 10.1074/ jbc.274.52.36912
17. Pittman RC, Steinberg D (1984) Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. J Lipid Res 25:1577-1585
18. Glass C, Pittman RC, Civen M et al (1985) Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem 260:744-750
19. Stein Y, Dabach Y, Hollander G et al (1983) Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim Biophys Acta 752:98-105
20. Glass C, Pittman RC, Weinstein DB et al (1983) Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci USA 80:5435-5439. doi: 10.1073/pnas.80.17.5435
21. Kozarsky KF, Donahee MH, Rigotti A et al (1997) Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387:414-417. doi: 10.1038/387414a0
22. Arai T, Rinninger F, Varban L et al (1999) Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci USA 96:12050-12055. doi: 10.1073/ pnas.96.21.12050
23. Shimamura M, Matsuda M, Yasumo H et al (2007) Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27:366-372. doi: 10.1161/ 01.ATV.0000252827.51626.89
24. Shimizugawa T, Ono M, Shimamura M et al (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277:33742-33748. doi: 10.1074/ jbc.M203215200
25. Morton RE, Gnizak HM, Greene DJ et al (2008) Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects. J Lipid Res 49:127-135. doi: 10.1194/ jlr.M700258-JLR200
26. Wang MD, Kiss RS, Franklin V et al (2007) Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways. J Lipid Res 48:633-645. doi: 10.1194/ jlr.M600470-JLR200
27. Plump AS, Scott CJ, Breslow JL (1994) Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 91:9607-9611. doi: 10.1073/pnas.91.20.9607
28. Paszty C, Maeda N, Verstuyft J et al (1994) Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94:899-903. doi: 10.1172/JCI117412
29. Boisvert WA, Black AS, Curtiss LK (1999) ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with apoE-expressing macrophages. Arterioscler Thromb Vasc Biol 19:525-530
30. Zabalawi M, Bhat S, Loughlin T et al (2003) Induction of fatal inflammation in LDL receptor and apoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 163:1201-1213
31. Srivastava RA (1994) Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism. Biochem Mol Biol Int 34:393-402
32. Peet DJ, Turley SD, Ma W et al (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR-a. Cell 93:693-704. doi: 10.1016/S0092-8674(00)81432-4
33. Yoshikawa T, Shimano H, Amemiya-Kudo M et al (2001) Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol 21:2991-3000. doi: 10.1128/MCB.21.9.2991-3000.2001
34. Zhang Y, Repa JJ, Gauthier K et al (2001) Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J Biol Chem 276:43018-43024. doi: 10.1074/jbc.M107823200
35. Schoonjans K, Gelman L, Haby C et al (2000) Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes. J Mol Biol 304:323-334. doi: 10.1006/jmbi.2000.4218
36. Latasa MJ, Moon YS, Kim KH et al (2000) Nutritional regulation of the fatty acid synthase promoter in vivo: Sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element. Proc Natl Acad Sci USA 97:10619-10624. doi: 10.1073/ pnas.180306597
37. Cagen LM, Deng X, Wilcox HG et al (2005) Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385:207-216. doi: 10.1042/BJ20040162
38. Liang Y, Jiang XC, Liu R et al (2004) Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists. Mol Endocrinol 18:2000-2010. doi: 10.1210/me.2003-0477
39. Qin X, Swertfeger DK, Zheng S et al (1998) Apolipoprotein AIV: A potent endogenous inhibitor of lipid oxidation. Am J Physiol 274:1836-1840
40. Zulewski H, Ninnis R, Miserez AR et al (1998) VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. J Lipid Res 39:380-387
41. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47. doi: 10.1126/science.3513311
42. Brissette L, Charest MC, Falstrault L (1996) Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem J 318:841-847
43. Truong TQ, Auger A, Denizeau F et al (2000) Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1484:307-315